Leveraging PAT, Digital Twins, & AI to Harmonize Analytics & Enable Regulatory‑Ready Manufacturing Decisions
- Integrating PAT data with AI and digital twins and harmonizing and contextualizing analytics to enable actionable insights and faster, better informed manufacturing decisions with less reliance on offline testing
- Developing and validating digital twins using FDA funded programs and regulator endorsed methodologies to gain regulatory confidence in advanced models, reduce risk and accelerate adoption in GMP manufacturing
- Replacing traditional analytical benchmarks with PAT and model-based approaches developed in collaboration with regulators to establish modern acceptance criteria that support successful filings while future proofing process control strategies